On June 30, 2025, the U.S. Department of Justice announced Operation Gold Rush, the largest loss amount it had ever charged in a health care fraud case. Prosecutors allege that a transnational criminal organization bought dozens of Medicare-enrolled medical supply companies through foreign straw owners and used the stolen identities of more than one million Americans to submit about $10.6 billion in false claims for urinary catheters and other durable medical equipment. It was part of the 2025 National Health Care Fraud Takedown, which charged 324 defendants over $14.6 billion in alleged fraud. This article explains how the scheme worked, how much was actually paid, and the lessons for practices and billing teams.
The Rise of Healthcare Fraud: A Growing Threat
Healthcare fraud has long been a challenge for systems worldwide, but the scale and complexity of the 2025 urinary catheter scheme mark a new era in criminal ingenuity. The U.S. healthcare system, with its vast expenditure and reliance on Medicare and Medicaid, presents a lucrative target for fraudsters. In 2023 alone, Medicare spending on medical supplies reached unprecedented levels, with urinary catheters accounting for a significant portion due to their low cost and high volume.
Warning signs appeared earlier. In 2024, the National Association of ACOs (NAACOS) reported a sudden spike in Medicare catheter billing in 2023, with far more beneficiaries billed than in prior years and payments in the billions, and asked CMS to investigate. That spike and the later Gold Rush charges point to the same weakness: high-volume, low-cost supplies billed under stolen identities.
Anatomy of the $10.6 Billion Scheme
How the Fraud Operated?
Stolen Identities and Shell Companies: Prosecutors say the group used the identities and confidential medical information of more than one million Americans, across all 50 states, to bill for catheters and other supplies patients never ordered or received. More than 400,000 people reported unexpected equipment notices in their names.
Exploitation of Low-Cost, High-Volume Items: Catheters are inexpensive per unit, so each claim looked small. The fraud relied on volume across many beneficiaries and many newly acquired supplier numbers.
The Role of Medicare’s Vulnerabilities
Medicare’s reimbursement system played a critical role in enabling the $10.6 billion scheme. A 2022 report by the Office of Inspector General (OIG) revealed that Medicare paid 3.4 times the acquisition cost for intermittent urinary catheters in 2020, with total payments of $407 million against suppliers’ acquisition costs of $121 million. This discrepancy created a financial incentive for fraudsters to target catheters, as the low cost and high reimbursement rates allowed for significant profits with minimal scrutiny.
A 2022 report by the Office of Inspector General (OIG) to: https://oig.hhs.gov/reports/all/2022/reducing-medicares-payment-rates-for-intermittent-urinary-catheters-can-save-the-program-and-beneficiaries-millions-of-dollars-each-year.
The OIG recommended that the Centers for Medicare and Medicaid Services (CMS) lower payment rates for intermittent catheters and incorporate them into competitive bidding programs to reduce costs. However, CMS had not implemented these changes by 2023, leaving the system vulnerable to exploitation. The lack of robust fraud detection mechanisms for low-cost, high-volume items like catheters further exacerbated the issue.
Impact on Victims and the Healthcare System
Victims of the Fraud
More than one million Medicare beneficiaries had their identities used. Most learned of it from a Medicare Summary Notice or a supplier’s call about catheters they never ordered. Because Medicare stopped most payments, few were billed directly, but their records now show supplies they never received, which can cause problems when they genuinely need supplies later. Beneficiaries should review each Medicare Summary Notice and report items they did not receive to 1-800-MEDICARE or the HHS OIG hotline.
Broader Implications for Healthcare
The urinary catheter scheme exposed systemic weaknesses in Medicare’s fraud prevention framework. The $10.6 billion in fraudulent claims strained an already burdened program, diverting resources from legitimate patient care. The broader $14.6 billion healthcare fraud takedown, of which the catheter scheme was a part, highlighted the growing threat of transnational criminal organizations targeting healthcare systems worldwide.
The scheme also underscored the need for greater oversight of durable medical equipment (DME) suppliers. The OIG’s 2022 report emphasized that high improper payment rates for urological supplies, including catheters, warranted closer scrutiny. The fact that Medicare payments exceeded suppliers’ acquisition costs by $286 million in 2020 alone illustrates the potential for abuse in the system.
The DOJ’s Response: Operation Gold Rush
The 2025 National Health Care Fraud Takedown, announced June 30, 2025, charged 324 defendants in cases involving about $14.6 billion in alleged fraud. Operation Gold Rush was its largest part: 19 defendants were charged, and 12 were arrested, including four in Estonia with Estonian law enforcement and seven at U.S. airports or the U.S.–Mexico border. The DOJ also announced a Health Care Fraud Data Fusion Center with HHS-OIG and the FBI, using data analytics to detect schemes like this earlier. CMS Administrator Dr. Mehmet Oz joined the announcement.
Massive Scale, Limited Payment:
The group submitted about $10.6 billion in claims, but most were not paid. According to the DOJ, about $4.45 billion was flagged for payment and CMS stopped all but roughly $41 million; Medicare supplemental insurers paid an estimated $900 million. Across the whole 2025 takedown, the government seized more than $245 million in cash, vehicles and cryptocurrency.
According to the DOJ, straw owners, some sent to the U.S. from Russia and Estonia, bought dozens of existing Medicare-enrolled supply companies across the country, opened bank accounts with false documents and acted on instructions sent over encrypted messaging. Charges were filed in five federal districts against 19 defendants. As with any criminal case, the defendants are presumed innocent unless proven guilty.
The Urinary Catheter Market: A Legitimate Industry Under Scrutiny
While the $10.6 billion scheme was a criminal enterprise, it operated within the context of a legitimate and growing urinary catheter market. According to industry reports, the global urinary catheters market were value at $6.45 billion in 2024 and is project to reach $9.75 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.10%. The market’s growth is driven by factors such as the rising prevalence of urinary incontinence, an aging population, and advancements in catheter technology.
Market Dynamics:
Intermittent catheters are a legitimate, necessary supply for people with urinary retention or neurogenic bladder. Medicare covers them under its urological supplies rules; a beneficiary who meets the criteria can generally receive up to 200 intermittent catheters per month with a valid order and supporting records.
How catheters are billed:
common HCPCS codes are A4351 (intermittent, straight tip), A4352 (intermittent, coudé tip) and A4353 (intermittent with insertion supplies). High payment relative to cost, shown in the OIG report above, is part of why these codes attract fraud. Honest suppliers now face more audits because of the scheme; accurate orders and documentation are their best protection.raud: Lessons from the Scheme
The $10.6 billion urinary catheter scheme offers critical lessons for preventing future healthcare fraud:
Enhanced Oversight of DME Suppliers: The OIG’s 2022 report recommended incorporating intermittent catheters into Medicare’s competitive bidding program to reduce payment rates and deter fraud. CMS must prioritize these reforms to close loopholes exploited by fraudsters.
Improved Fraud Detection Systems: Medicare’s current systems are ill-equipped to detect high-volume, low-cost fraud. Advanced analytics and real-time monitoring could help identify suspicious billing patterns before they escalate.
International Cooperation: The transnational nature of the scheme underscores the need for global collaboration in combating healthcare fraud. Partnerships with agencies like Interpol can help track and apprehend perpetrators operating across borders.
Patient Education and Protection: Raising awareness among Medicare beneficiaries about fraudulent billing practices can empower them to report suspicious activity. Additionally, stronger data security measures are need to prevent identity theft.
Regulatory Reforms: Stricter regulations for DME suppliers, including mandatory audits and verification of medical necessity, could deter fraudulent claims. The DOJ’s success in Operation Gold Rush demonstrates the effectiveness of proactive enforcement.
What Practices and Billing Teams Should Do
- Never sign unsolicited DME orders: sign only for patients you evaluated and supplies you judge medically necessary.
- Protect your NPI: watch for claims or orders under your NPI that you did not create; check your Medicare enrollment regularly.
- Screen vendors and staff: check the OIG List of Excluded Individuals/Entities before hiring or contracting.
Vet your billing company: billing vendors have been at the center of large schemes, such as the one described in our article on the $650 million Arizona Medicaid fraud. See our checklist on how to choose a billing company.
The Broader Context: Healthcare Fraud in 2025
The $10.6 billion urinary catheter scheme was part of a larger $14.6 billion healthcare fraud takedown, reflecting a growing trend of sophisticated criminal activity in the sector. Transnational criminal organizations are increasingly targeting healthcare systems, exploiting vulnerabilities in digital infrastructure and reimbursement processes. The DOJ’s response, while significant, highlights the need for systemic reforms to address this evolving threat.
Other healthcare fraud schemes uncovered in 2025 included fraudulent billing for durable medical equipment, prescription drugs, and telehealth services. These schemes often involve similar tactics, such as identity theft and shell companies, underscoring the need for a comprehensive approach to fraud prevention.
Frequently Asked Questions
What is the $10.6 Billion Urinary Catheter Scheme of 2025?
The DOJ announced the case in June 2025 after investigators alleged that a transnational criminal organization used dozens of Medicare-enrolled supply companies and the stolen identities of more than one million Americans to submit about $10.6 billion in false claims for urinary catheters and other DME. The DOJ described it as the largest loss amount it had ever charged.
The charged 19 defendants in Operation Gold Rush and arrested 12, as part of a national takedown that charged 324 defendants overall. CMS blocked most of the Medicare payments, and the government seized more than $245 million in assets across the takedown.
How did the fraudsters execute the urinary catheter scheme?
Criminals acquired medical supply companies through straw owners and used stolen personal information from over one million Americans to create fake patient profiles. They submitted fraudulent Medicare claims for high volumes of urinary catheters, exploiting the low oversight of low-cost medical supplies. The scheme was coordinate internationally, with operatives in countries like Russia and Estonia laundering funds through offshore accounts.
Who were the victims of the $10.6 billion scheme?
Over one million Medicare beneficiaries, primarily elderly Americans, were affectees. Their stolen identities were use to bill Medicare for catheters they never receive or need, leading to financial distress and privacy violations. Many victims only discover the fraud when they received unexpected bills or noticed unauthorized charges on their Medicare accounts.
What actions did the Department of Justice take to address the scheme?
In June 2025, the DOJ launched “Operation Gold Rush,” charging over 320 individuals and uncovering $14.6 billion in fraudulent claims, with $10.6 billion tied to the catheter scheme. Authorities seized $245 million in assets, including cash, luxury vehicles, and cryptocurrency. Nineteen individuals were arrest, including four in Estonia and seven at U.S. borders, highlighting international cooperation.
How can future urinary catheter fraud be prevented?
Preventing similar fraud requires enhanced oversight of durable medical equipment suppliers, improved Medicare fraud detection systems using advanced analytics, and stricter regulations like competitive bidding for catheters. International law enforcement collaboration, patient education on spotting fraudulent billing, and stronger data security to prevent identity theft are also critical measures.
How much did Medicare actually pay in Operation Gold Rush?
According to the Justice Department, officials flagged about $4.45 billion in claims for payment, but CMS stopped all except roughly $41 million. Medicare supplemental insurers paid an estimated $900 million.
How many people were charged in Operation Gold Rush?
Authorities charged 19 defendants in Operation Gold Rush and arrested 12, including four in Estonia and seven at U.S. airports or the U.S.–Mexico border. The wider 2025 National Health Care Fraud Takedown charged 324 defendants.
How many intermittent catheters does Medicare cover?
Under Medicare’s urological supplies coverage rules, a beneficiary who meets the criteria can generally receive up to 200 intermittent catheters per month, billed with HCPCS codes such as A4351, A4352 or A4353, with a valid order and supporting records.
What should a practice do if a supplier asks it to sign catheter orders?
Only sign orders for patients you have actually evaluated and for supplies you believe are medically necessary. Unsolicited requests to sign DME orders for unknown patients are a common fraud red flag; report them to the HHS OIG hotline.
Final Thoughts
The $10.6 billion urinary catheter scheme of 2025 stands as a stark reminder of the vulnerabilities in the U.S. healthcare system. By exploiting Medicare’s reimbursement system and leveraging stolen identities, transnational criminal organizations orchestrated one of the largest healthcare frauds in history. The scheme’s impact, affecting over one million Americans and straining Medicare’s resources, underscores the urgent need for reform.
$10.6 Billion Urinary Catheter Fraud-Operation Gold Rush, with its unprecedented seizures and arrests, marks a significant step in combating healthcare fraud. However, preventing future schemes will require enhanced oversight, advanced fraud detection, international cooperation, and robust patient protections. As the legitimate urinary catheter market continues to grow, driven by an aging population and technological advancements, policymakers must balance innovation with vigilance to safeguard the integrity of the healthcare system.
The $10.6 billion scheme is not just a financial crime; it is a betrayal of trust that undermines the foundation of healthcare delivery. By learning from this scandal, stakeholders can strengthen the system, ensuring that resources are direct to those who need them most—patients seeking care, not criminals seeking profit.
Key Market Player
Ready to optimize your medical billing and boost your revenue? Look no further. Zmed Solutions LLC is your trusted partner in professional Medical Billing Services.
Join our growing network of healthcare providers who have already elevated their revenue with our expert services. Don't miss out on what could be your practice's most profitable decision.
Schedule a Consultation Today!
Contact Us Now, and experience the difference. Your financial success starts here!
